Pembrolizumab plus Chemotherapy Study in Metastatic Lung Cancer
There is a new first-line therapy which helps people with advanced non-small-cell lung cancer (NSCLC). Its name is platinum-based chemotherapy and it lacks any targetable mutations. The pembrolizumab substance has recently replaced the cytotoxic chemotherapy as the first-line treatment. This…